Generic Penetration in the Retail Antidepressant Market

| June 29, 2010 | 0 Comments

by Jeffrey Ventimiglia and Amir H. Kalali, MD
Mr. Ventimiglia is Analyst, Strategy and Solutions, Global Customer Management, Quintiles, Inc., Durham, North Carolina; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles, Inc., and Professor of Psychiatry, University of California, San Diego, California.

Psychiatry (Edgemont) 2010;7(6):9–11

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , , , ,

Category: Mood Disorders, Past Articles, Psychiatry, Psychopharmacology, Trend Watch

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.